MX9305138A - LIPIDS FOR EPIDERMIC HUMIDIFICATION AND REPAIR OF THE BARRIER FUNCTION. - Google Patents

LIPIDS FOR EPIDERMIC HUMIDIFICATION AND REPAIR OF THE BARRIER FUNCTION.

Info

Publication number
MX9305138A
MX9305138A MX9305138A MX9305138A MX9305138A MX 9305138 A MX9305138 A MX 9305138A MX 9305138 A MX9305138 A MX 9305138A MX 9305138 A MX9305138 A MX 9305138A MX 9305138 A MX9305138 A MX 9305138A
Authority
MX
Mexico
Prior art keywords
lipids
barrier function
epidermic
humidification
repair
Prior art date
Application number
MX9305138A
Other languages
Spanish (es)
Inventor
Peter M Elias
Kenneth R Feingold
Carl R Thornfeldt
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX9305138A publication Critical patent/MX9305138A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención se relaciona con la aplicación de lípidos y formulaciones de lípidos y con el tratamiento de pacientes que adolecen de enfermedades o transtornos de la piel o de la membrana mucosa que exhiben hiperproliferación epidérmica y desgarramientos de la función de barrera.This invention relates to the application of lipids and lipid formulations and to the treatment of patients suffering from diseases or disorders of the skin or mucous membrane that exhibit epidermal hyperproliferation and tears of barrier function.

MX9305138A 1992-09-29 1993-08-25 LIPIDS FOR EPIDERMIC HUMIDIFICATION AND REPAIR OF THE BARRIER FUNCTION. MX9305138A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95293492A 1992-09-29 1992-09-29
US95360392A 1992-09-29 1992-09-29

Publications (1)

Publication Number Publication Date
MX9305138A true MX9305138A (en) 1994-05-31

Family

ID=27130334

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305138A MX9305138A (en) 1992-09-29 1993-08-25 LIPIDS FOR EPIDERMIC HUMIDIFICATION AND REPAIR OF THE BARRIER FUNCTION.

Country Status (2)

Country Link
MX (1) MX9305138A (en)
TW (1) TW250434B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2829303A1 (en) * 2013-07-22 2015-01-28 Johnson & Johnson Consumer Companies Inc. Compositions comprising extract of malva neglecta and method of treating a skin condition with malva neglecta

Also Published As

Publication number Publication date
TW250434B (en) 1995-07-01

Similar Documents

Publication Publication Date Title
BR9713677A (en) Gel formulations for topical drug release
ES2194107T3 (en) PHARMACEUTICAL AND DIETETIC FORMULATIONS FOR PROFILAXIS AND TREATMENT OF GASTROINTESTINAL DISORDERS.
BR9611802A (en) Pharmaceutical compositions
BR9911071A (en) Preparations for the application of anti-inflammatory agents, especially antiseptics and / or agents that promote healing of wounds in the upper respiratory tract and / or the ear
ES2145052T3 (en) LIPIDS FOR EPIDERMIC HUMIDIFICATION AND REPAIR OF THE BARRIER FUNCTION.
BR9810312A (en) Pharmaceutical composition that has marked antitumor activity and / or reduced side effects containing an antitumor agent and a derivative of hydroxy acid
BR9712491A (en) Cosmetic compositions
AR026610A1 (en) A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
BR0008323A (en) Gabapentin derivative for the prevention and treatment of visceral pain
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
AR002023A1 (en) NON-THERAPEUTIC USE OF AT LEAST AN ANTAGONIST OF THE PEPTIDE DERIVED FROM THE CALCITONINE GENE IS TO SAY AN ANTAGONIST OF CGRP, USE OF SUCH ANTAGONIST FOR THE PREPARATION OF A COMPOSITION THAT IS A DERMATOLOGICALLY COMPUTATION AND A PHARMACEUTICAL PRODUCT TOPIC THAT INCLUDES SUCH ANTAGONIST
ES2169197T3 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ALCANOIL L-CARNITINE IN COMBINATION WITH A POLYINSATURED FATTY ACID OF THE OMEGA-3 SERIES FOR THE PREVENTION AND TREATMENT OF LIPID METABOLISM DISORDERS.
BR9914044A (en) tetrahydropyride esters
ES2153394T3 (en) MEDICINAL PRODUCT CONTAINING THE P40 SUBUNITY OF INTERLEUQUINA-12.
HUP0100539A2 (en) Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
ES2111355T3 (en) L-CARNITINE SALT AND COSMETIC AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR THE TREATMENT OF DERMATOSIS.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
BR9607967A (en) Use of immunomodular compositions extracted from bile to treat disorders of the immune system, manufacture of the drug and use of it
EP0699444A3 (en) Composition for the treatment of intestinal wounds or ulcers containing proteins, carbohydrates and fat
DE69626987D1 (en) PHARMACEUTICAL COMPOSITION
MX9305138A (en) LIPIDS FOR EPIDERMIC HUMIDIFICATION AND REPAIR OF THE BARRIER FUNCTION.
PT900563E (en) PRODUCTION OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF EDEMA AND VENOUS DISEASES
ES2110057T3 (en) MEDICINAL COMPOSITION CONTAINING TCF-II.
AR059965A2 (en) USE OF 8,9-DEHYDROESTRONE FOR THE PREPARATION OF AN ANTIOXIDANT MEDICINAL PRODUCT
BR0004813A (en) Vesicular constructs marked for cytoprotection and treatment of infections by h. pylori